Antonio Inserra

1.7k total citations
30 papers, 1.2k citations indexed

About

Antonio Inserra is a scholar working on Clinical Psychology, Biological Psychiatry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Antonio Inserra has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Clinical Psychology, 15 papers in Biological Psychiatry and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Antonio Inserra's work include Psychedelics and Drug Studies (16 papers), Tryptophan and brain disorders (15 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Antonio Inserra is often cited by papers focused on Psychedelics and Drug Studies (16 papers), Tryptophan and brain disorders (15 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). Antonio Inserra collaborates with scholars based in Canada, Italy and Australia. Antonio Inserra's co-authors include Ma‐Li Wong, Julio Licínio, Geraint B. Rogers, Gabriella Gobbi, Danilo De Gregorio, Claudio A. Mastronardi, Martin Lewis, Jocelyn M. Choo, Lex E. X. Leong and Stephen J. Kentish and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Scientific Reports and Pharmacological Reviews.

In The Last Decade

Antonio Inserra

26 papers receiving 1.2k citations

Peers

Antonio Inserra
Antonio Inserra
Citations per year, relative to Antonio Inserra Antonio Inserra (= 1×) peers Yuly Bersudsky

Countries citing papers authored by Antonio Inserra

Since Specialization
Citations

This map shows the geographic impact of Antonio Inserra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Inserra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Inserra more than expected).

Fields of papers citing papers by Antonio Inserra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Inserra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Inserra. The network helps show where Antonio Inserra may publish in the future.

Co-authorship network of co-authors of Antonio Inserra

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Inserra. A scholar is included among the top collaborators of Antonio Inserra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Inserra. Antonio Inserra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathias, Khiany, Mariana Pereira de Souza Goldim, Betine Pinto Moehlecke Iser, et al.. (2025). Cannabidiol reverses myeloperoxidase hyperactivity in the prefrontal cortex and striatum, and reduces protein carbonyls in the hippocampus in a ketamine-induced schizophrenia rat model. Schizophrenia Research. 278. 82–95.
2.
Inserra, Antonio, Thomas Prudhomme, Marco Leyton, et al.. (2025). Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 142. 111522–111522.
3.
Semeraro, Francesco, Antonio Inserra, Luisa De Risio, et al.. (2025). Endocannabinoids, depression, and treatment resistance: Perspectives on effective therapeutic interventions. Psychiatry Research. 352. 116697–116697.
4.
Inserra, Antonio, Emily Grant, Antonella Bertazzo, et al.. (2025). Pharmacological characterization of cannabidiol as a negative allosteric modulator of the 5-HT2A receptor. Cellular Signalling. 127. 111588–111588. 5 indexed citations
5.
Inserra, Antonio, et al.. (2024). Epigenetic mechanisms of rapid-acting antidepressants. Translational Psychiatry. 14(1). 359–359. 15 indexed citations
6.
Campanale, Antonella, Antonio Inserra, & Stefano Comai. (2024). Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 134. 111058–111058. 12 indexed citations
7.
Onofrj, Marco, Mirella Russo, Stefano Delli Pizzi, et al.. (2023). The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics. Translational Psychiatry. 13(1). 384–384. 13 indexed citations
8.
Inserra, Antonio, et al.. (2023). Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence. CNS Drugs. 37(9). 733–754. 9 indexed citations
9.
Gobbi, Gabriella, Antonio Inserra, Kyle T. Greenway, Michael Lifshitz, & Laurence J. Kirmayer. (2022). Psychedelic medicine at a crossroads: Advancing an integrative approach to research and practice. Transcultural Psychiatry. 59(5). 718–724. 5 indexed citations
10.
Inserra, Antonio, Sébastien Lacroix, Antonella Bertazzo, et al.. (2022). Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome. British Journal of Pharmacology. 180(6). 721–739. 19 indexed citations
11.
Markopoulos, Athanasios, Antonio Inserra, Danilo De Gregorio, & Gabriella Gobbi. (2022). Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder. Frontiers in Pharmacology. 12. 749068–749068. 28 indexed citations
12.
Gregorio, Danilo De, Jelena Popić, Justine P. Enns, et al.. (2021). Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission. Proceedings of the National Academy of Sciences. 118(5). 89 indexed citations
13.
Inserra, Antonio, Danilo De Gregorio, & Gabriella Gobbi. (2020). Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. Pharmacological Reviews. 73(1). 202–277. 155 indexed citations
14.
Li, Hui, Femke Buisman‐Pijlman, Claudine L. Frisby, et al.. (2019). Chronic stress induces hypersensitivity of murine gastric vagal afferents. Neurogastroenterology & Motility. 31(12). e13669–e13669. 23 indexed citations
15.
Inserra, Antonio, Jocelyn M. Choo, Martin Lewis, et al.. (2019). Mice lacking Casp1, Ifngr and Nos2 genes exhibit altered depressive- and anxiety-like behaviour, and gut microbiome composition. Scientific Reports. 9(1). 6456–6456. 16 indexed citations
16.
Inserra, Antonio. (2018). Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process. Frontiers in Pharmacology. 9. 330–330. 61 indexed citations
17.
Inserra, Antonio, Claudio A. Mastronardi, Geraint B. Rogers, Julio Licínio, & Ma‐Li Wong. (2018). Neuroimmunomodulation in Major Depressive Disorder: Focus on Caspase 1, Inducible Nitric Oxide Synthase, and Interferon-Gamma. Molecular Neurobiology. 56(6). 4288–4305. 75 indexed citations
18.
Inserra, Antonio, Geraint B. Rogers, Julio Licínio, & Ma‐Li Wong. (2018). The Microbiota‐Inflammasome Hypothesis of Major Depression. BioEssays. 40(9). e1800027–e1800027. 112 indexed citations
19.
Wong, Ma‐Li, Antonio Inserra, Martin Lewis, et al.. (2016). Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition. Molecular Psychiatry. 21(6). 797–805. 441 indexed citations
20.
Paz-Filho, Gilberto, Claudio A. Mastronardi, Brian J. Parker, et al.. (2013). Molecular pathways involved in the improvement of non-alcoholic fatty liver disease. Journal of Molecular Endocrinology. 51(1). 167–179. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026